Eudragit®: A Versatile Family of Polymers for Hot Melt Extrusion and 3D Printing Processes in Pharmaceutics
J Dos Santos, GS da Silva, MC Velho, RCR Beck - Pharmaceutics, 2021 - mdpi.com
Eudragit® polymers are polymethacrylates highly used in pharmaceutics for the
development of modified drug delivery systems. They are widely known due to their …
development of modified drug delivery systems. They are widely known due to their …
Hot melt extrusion technique for developing pharmaceutical co-crystals: a review
Background: In the era of pharmaceutical research and development, the most challenging
aspect is to enhance the physicochemical properties of drugs. Hot Melt Extrusion (HME) is a …
aspect is to enhance the physicochemical properties of drugs. Hot Melt Extrusion (HME) is a …
Simulation of mesalazine solubility in the binary solvents at various temperatures
E Mohammadian, A Foroumadi, Z Hasanvand… - Journal of Molecular …, 2022 - Elsevier
The present study aims are to develop general models based on Abraham solvation
parameters and Hansen solubility parameters to predict mesalazine solubility in cosolvency …
parameters and Hansen solubility parameters to predict mesalazine solubility in cosolvency …
[HTML][HTML] Hot melt extrusion for enhanced dissolution and intestinal absorption of hydrochlorothiazide
Hydrochlorothiazide (HTZ) is a potent thiazide diuretic that is used in the management of
hypertension. However, HTZ suffers from low and variable oral bioavailability owing to its …
hypertension. However, HTZ suffers from low and variable oral bioavailability owing to its …
Recent advances in techniques for enhancing the solubility of hydrophobic drugs.
Z Xu, S Lin, Q Li, S Jiang, P Wang - Pakistan Journal of …, 2022 - go.gale.com
Numerous hydrophobic compounds are important ingredients for drug discovery and
development. Hydrophobicity has been a major hurdle limiting the therapeutic efficacy of …
development. Hydrophobicity has been a major hurdle limiting the therapeutic efficacy of …
[PDF][PDF] Development and characterization of leuprolide acetate encapsulated PLGA microspheres for parenteral controlled release depot injection
SR Satapathy, RN Sahoo, B Satapathy… - Indian J. Pharm. Educ …, 2021 - academia.edu
Objectives: Polylactic acid (PLA) and copolymer polylactic-co-glycolic acid (PLGA) are the
most versatile drug carriers for long acting release injectable (LAI) formulations for small …
most versatile drug carriers for long acting release injectable (LAI) formulations for small …
[PDF][PDF] Evaluation of the granulometry impact of the compression mixture in the formulation development of tablets
C Donea, DE Popa, AM Ciobanu, P Crăciun… - …, 2022 - farmaciajournal.com
The aim of this research was the preformulation and preliminary formulation studies of oral
gastro-resistant tablets containing 500 mg mesalazine. Increased compliance of the …
gastro-resistant tablets containing 500 mg mesalazine. Increased compliance of the …
Crystal products of lamotrigine-citric acid for improvement of in vitro drug release in simulated gastric fluid
BS Satapathy, A Patel, RN Sahoo… - Journal of the Serbian …, 2021 - shd-pub.org.rs
Crystal engineering is an integral part of the drug development research. Crystal forms can
modify the physicochemical properties of the parent drug molecule. The present work was …
modify the physicochemical properties of the parent drug molecule. The present work was …
Release Rate Studies of 5-Aminosalacylic Acid Coated with Atomic Layer-Deposited Al2O3 and ZnO in an Acidic Environment
5-Aminosalicylic acid (5-ASA) is a first-line defense drug used to treat mild cases of
inflammatory bowel disease. When administered orally, the active pharmaceutical ingredient …
inflammatory bowel disease. When administered orally, the active pharmaceutical ingredient …
[PDF][PDF] Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate
Purpose: Oral drug delivery system has always been a preferred choice for the treatment of
peptic ulcer and gastroesophageal reflux diseases. Being a proton pump inhibitor …
peptic ulcer and gastroesophageal reflux diseases. Being a proton pump inhibitor …